Mutant Met-Mediated Transformation Is Ligand-Dependent and Can Be Inhibited by HGF Antagonists

Oncogene - United Kingdom
doi 10.1038/sj.onc.1202899
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tumorigenesis Mediated by MET Mutant M1268T Is Inhibited by Dominant-Negative SRC

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

WT1-mediated Transcriptional Activation Is Inhibited by Dominant Negative Mutant Proteins

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Hypoxia Increases Heparanase-Dependent Tumor Cell Invasion, Which Can Be Inhibited by Antiheparanase Antibodies

Cancer Research
Cancer ResearchOncology
2004English

Nonhomologous End-Joining Can Be Pharmacologically Inhibited

Cancer Discovery
Oncology
2013English

P2.13-21 MET Addiction Can Be Circumvented Through EGFR Inhibition via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Scrib Regulates HGF-mediated Epithelial Morphogenesis and Is Stabilized by Sgt1-Hsp90

Journal of Cell Science
Cell Biology
2012English

Ubiquitin-Dependent Degradation of P73 Is Inhibited by PML

Journal of Experimental Medicine
MedicineAllergyImmunology
2004English

The HAB1 PP2C Is Inhibited by ABA-dependent PYL10 Interaction

Scientific Reports
Multidisciplinary
2015English

Clathrin-Mediated Endocytosis Is Inhibited During Mitosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy